Symbols / ACH $3.46 +3.90% Accendra Health, Inc.
ACH Chart
About
Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services. The company also supplies other home medical equipment, patient care product lines including ostomy, wound care and negative pressure wound therapy, urology, incontinence, and other products and services. It serves patients and home health agencies. The company was formerly known as Owens & Minor, Inc. and changed its name to Accendra Health, Inc. in December 2025. Accendra Health, Inc. was founded in 1882 and is based in Glen Allen, Virginia.
Fundamentals
Scroll to Statements| Market Cap | 264.48M | Enterprise Value | 2.15B | Income | -102.68M | Sales | 2.76B | Book/sh | -6.04 | Cash/sh | 3.69 |
| Dividend Yield | — | Payout | 0.00% | Employees | 6500 | IPO | — | P/E | — | Forward P/E | 3.33 |
| PEG | 0.70 | P/S | 0.10 | P/B | -0.57 | P/C | — | EV/EBITDA | 5.95 | EV/Sales | 0.78 |
| Quick Ratio | 0.40 | Current Ratio | 0.58 | Debt/Eq | — | LT Debt/Eq | — | EPS (ttm) | -1.34 | EPS next Y | 1.04 |
| EPS Growth | — | Revenue Growth | -73.70% | Earnings | 2026-05-07 | ROA | 2.57% | ROE | -163.78% | ROIC | — |
| Gross Margin | 46.68% | Oper. Margin | 2.94% | Profit Margin | -39.85% | Shs Outstand | 76.44M | Shs Float | 55.91M | Short Float | 12.19% |
| Short Ratio | 8.85 | Short Interest | — | 52W High | 9.55 | 52W Low | 1.84 | Beta | 1.26 | Avg Volume | 900.84K |
| Volume | 549.96K | Target Price | $3.25 | Recom | None | Prev Close | $3.33 | Price | $3.46 | Change | 3.90% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-02-20 | main | Leerink Partners | Market Perform → Market Perform | $3 |
| 2026-01-09 | main | Citigroup | Buy → Buy | $4 |
| 2025-11-03 | down | UBS | Buy → Neutral | $4 |
| 2025-08-27 | main | JP Morgan | Underweight → Underweight | $6 |
| 2025-08-13 | main | UBS | Buy → Buy | $7 |
| 2025-08-12 | main | Baird | Outperform → Outperform | $7 |
| 2025-08-12 | main | Citigroup | Buy → Buy | $7 |
| 2025-08-12 | main | B of A Securities | Underperform → Underperform | $5 |
News
RSS: Latest ACH news- What is the outlook for Accendra (ACH) stock this quarter | Q4 2025: EPS Misses Estimates - Community Trade Ideas - Cổng thông tin điện tử Tỉnh Sơn La Wed, 22 Apr 2026 21
- What is the outlook for Accendra (ACH) stock this quarter | Q4 2025: EPS Misses Estimates - Best Pick - Cổng thông tin điện tử tỉnh Lào Cai Wed, 22 Apr 2026 23
- ACH Stock Price, News & Analysis | Accendra Health - Stock Titan Fri, 17 Apr 2026 07
- symbol__ Stock Quote Price and Forecast - CNN Sat, 03 Jan 2026 17
- Accendra Health (ACH) Reports 2025 Revenue of $2.8B and Shift Toward Core Home-Based Care - Yahoo Finance ue, 24 Feb 2026 08
- ACH.W Stock Price, Quote & Chart | ARCHER AVIATION INC -CW26 (NYSE:ACH.W) - ChartMill Fri, 10 Apr 2026 07
- Accendra Health: Debt Reduction Creates Long-Term Opportunity (Upgrade) (NYSE:ACH) - Seeking Alpha Fri, 20 Feb 2026 08
- Accendra Health (ACH): Citigroup Lowers Price Target, Maintains Buy Rating | ACH Stock News - GuruFocus Fri, 09 Jan 2026 08
- ACH Options Volatility — NYSE:ACH - TradingView Sat, 11 Apr 2026 22
- Implied Volatility Surging for Accendra Health Stock Options - Yahoo Finance hu, 08 Jan 2026 08
- Home-based care group Accendra nets $342M from business sale - Stock Titan hu, 19 Feb 2026 08
- Is Accendra (ACH) Stock Good for Short Term | Price at $2.69, Up 2.28% - Day Trade - Cổng thông tin điện tử tỉnh Lào Cai Mon, 06 Apr 2026 07
- Accendra Health, Inc. to Begin Trading on NYSE under New Ticker "ACH" - Yahoo Finance Fri, 02 Jan 2026 08
- Kevin M. Webb reports 5.61% stake in Accendra Health (NASDAQ: ACH) - Stock Titan Mon, 30 Mar 2026 07
- [ARS] ACCENDRA HEALTH INC/VA/ SEC Filing - Stock Titan hu, 02 Apr 2026 07
Insider Transactions
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
2,762.03
+3.06%
|
2,680.11
+5.00%
|
2,552.57
-74.36%
|
9,955.48
|
| Operating Revenue |
|
2,762.03
+3.06%
|
2,680.11
+5.00%
|
2,552.57
-74.36%
|
9,955.48
|
| Cost Of Revenue |
|
1,472.73
+5.22%
|
1,399.73
+4.81%
|
1,335.55
-83.57%
|
8,129.12
|
| Reconciled Cost Of Revenue |
|
1,472.73
+5.22%
|
1,399.73
+4.81%
|
1,335.55
-83.57%
|
8,129.12
|
| Gross Profit |
|
1,289.30
+0.70%
|
1,280.38
+5.21%
|
1,217.02
-33.36%
|
1,826.35
|
| Operating Expense |
|
1,067.56
-1.37%
|
1,082.34
+8.06%
|
1,001.66
-35.36%
|
1,549.57
|
| Selling General And Administration |
|
1,067.56
-1.37%
|
1,082.34
+8.06%
|
1,001.66
-35.58%
|
1,554.82
|
| Other Operating Expenses |
|
—
|
13.32
+92.15%
|
6.93
+231.95%
|
-5.25
|
| Total Expenses |
|
2,540.29
+2.35%
|
2,482.08
+6.20%
|
2,337.21
-75.85%
|
9,678.69
|
| Operating Income |
|
221.74
+11.97%
|
198.04
-8.05%
|
215.36
-22.19%
|
276.78
|
| Total Operating Income As Reported |
|
27.46
+112.61%
|
-217.73
-263.42%
|
133.23
-6.77%
|
142.91
|
| EBITDA |
|
219.75
+635.49%
|
-41.04
-111.99%
|
342.40
-7.07%
|
368.45
|
| Normalized EBITDA |
|
432.32
+15.37%
|
374.73
-11.73%
|
424.54
-15.48%
|
502.32
|
| Reconciled Depreciation |
|
214.52
+18.34%
|
181.28
-13.83%
|
210.37
-8.00%
|
228.67
|
| EBIT |
|
5.23
+102.35%
|
-222.32
-268.38%
|
132.03
-5.54%
|
139.78
|
| Total Unusual Items |
|
-212.57
+48.87%
|
-415.77
-406.21%
|
-82.13
+38.65%
|
-133.87
|
| Total Unusual Items Excluding Goodwill |
|
-212.57
+48.87%
|
-415.77
-406.21%
|
-82.13
+38.65%
|
-133.87
|
| Special Income Charges |
|
-212.57
+48.87%
|
-415.77
-406.21%
|
-82.13
+38.65%
|
-133.87
|
| Other Special Charges |
|
—
|
1.10
+131.30%
|
-3.52
|
—
|
| Impairment Of Capital Assets |
|
0.00
-100.00%
|
307.11
|
0.00
|
0.00
|
| Restructuring And Mergern Acquisition |
|
212.57
+95.64%
|
108.65
+32.29%
|
82.13
-38.65%
|
133.87
|
| Net Income |
|
-1,100.64
-203.47%
|
-362.69
-778.15%
|
-41.30
-284.47%
|
22.39
|
| Pretax Income |
|
-101.95
+69.09%
|
-329.88
-2261.05%
|
15.27
+40.16%
|
10.89
|
| Net Non Operating Interest Income Expense |
|
-107.18
+0.36%
|
-107.57
+7.88%
|
-116.77
+9.40%
|
-128.89
|
| Interest Expense Non Operating |
|
107.18
-0.36%
|
107.57
-7.88%
|
116.77
-9.40%
|
128.89
|
| Net Interest Income |
|
-107.18
+0.36%
|
-107.57
+7.88%
|
-116.77
+9.40%
|
-128.89
|
| Interest Expense |
|
107.18
-0.36%
|
107.57
-7.88%
|
116.77
-9.40%
|
128.89
|
| Other Income Expense |
|
-216.51
+48.49%
|
-420.36
-404.45%
|
-83.33
+39.18%
|
-137.00
|
| Other Non Operating Income Expenses |
|
-3.94
+14.10%
|
-4.59
-283.38%
|
-1.20
+61.77%
|
-3.13
|
| Tax Provision |
|
0.73
-96.50%
|
20.85
+227.83%
|
6.36
+155.31%
|
-11.50
|
| Tax Rate For Calcs |
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
|
| Tax Effect Of Unusual Items |
|
-44.64
+48.87%
|
-87.31
-406.21%
|
-17.25
+38.65%
|
-28.11
|
| Net Income Including Noncontrolling Interests |
|
-1,100.64
-203.47%
|
-362.69
-778.15%
|
-41.30
-284.47%
|
22.39
|
| Net Income From Continuing Operation Net Minority Interest |
|
-102.68
+70.72%
|
-350.74
-4038.63%
|
8.90
-60.23%
|
22.39
|
| Net Income From Continuing And Discontinued Operation |
|
-1,100.64
-203.47%
|
-362.69
-778.15%
|
-41.30
-284.47%
|
22.39
|
| Net Income Continuous Operations |
|
-102.68
+70.72%
|
-350.74
-4038.63%
|
8.90
-60.23%
|
22.39
|
| Net Income Discontinuous Operations |
|
-997.96
-8250.43%
|
-11.95
+76.20%
|
-50.21
|
0.00
|
| Normalized Income |
|
65.25
+392.85%
|
-22.28
-130.19%
|
73.79
-42.42%
|
128.15
|
| Net Income Common Stockholders |
|
-1,100.64
-203.47%
|
-362.69
-778.15%
|
-41.30
-284.47%
|
22.39
|
| Diluted EPS |
|
—
|
-4.73
-775.93%
|
-0.54
-286.21%
|
0.29
|
| Basic EPS |
|
—
|
-4.73
-775.93%
|
-0.54
-280.00%
|
0.30
|
| Basic Average Shares |
|
—
|
76.74
+1.26%
|
75.78
+1.73%
|
74.50
|
| Diluted Average Shares |
|
—
|
76.74
+1.26%
|
75.78
-0.57%
|
76.22
|
| Diluted NI Availto Com Stockholders |
|
-1,100.64
-203.47%
|
-362.69
-778.15%
|
-41.30
-284.47%
|
22.39
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
2,451.76
-47.34%
|
4,656.16
-8.58%
|
5,093.32
-5.44%
|
5,386.28
|
| Current Assets |
|
547.87
-72.89%
|
2,021.02
-3.89%
|
2,102.79
-8.38%
|
2,295.18
|
| Cash Cash Equivalents And Short Term Investments |
|
281.99
+922.74%
|
27.57
-88.66%
|
243.04
+249.86%
|
69.47
|
| Cash And Cash Equivalents |
|
281.99
+922.74%
|
27.57
-88.66%
|
243.04
+249.86%
|
69.47
|
| Receivables |
|
95.91
-56.06%
|
218.27
-63.52%
|
598.26
-21.64%
|
763.50
|
| Accounts Receivable |
|
95.91
-56.06%
|
218.27
-63.52%
|
598.26
-21.64%
|
763.50
|
| Gross Accounts Receivable |
|
103.58
-54.10%
|
225.67
-62.77%
|
606.16
-21.54%
|
772.60
|
| Allowance For Doubtful Accounts Receivable |
|
-7.68
-3.71%
|
-7.40
+6.29%
|
-7.90
+13.19%
|
-9.10
|
| Inventory |
|
74.44
+10.14%
|
67.58
-93.91%
|
1,110.61
-16.72%
|
1,333.59
|
| Raw Materials |
|
—
|
77.92
+2.92%
|
75.71
|
—
|
| Work In Process |
|
—
|
59.12
-3.92%
|
61.53
|
—
|
| Finished Goods |
|
74.44
+10.14%
|
67.58
-93.57%
|
1,051.55
-21.15%
|
1,333.59
|
| Assets Held For Sale Current |
|
0.00
-100.00%
|
1,625.35
|
—
|
—
|
| Other Current Assets |
|
95.54
+16.17%
|
82.24
-45.50%
|
150.89
+17.30%
|
128.64
|
| Total Non Current Assets |
|
1,903.89
-27.75%
|
2,635.14
-11.88%
|
2,990.53
-3.25%
|
3,091.10
|
| Net PPE |
|
365.26
-2.91%
|
376.21
-55.24%
|
840.50
-2.15%
|
858.93
|
| Gross PPE |
|
572.86
+2.30%
|
559.96
-59.63%
|
1,386.90
+5.93%
|
1,309.22
|
| Accumulated Depreciation |
|
-207.59
-12.98%
|
-183.75
+66.37%
|
-546.40
-21.34%
|
-450.29
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Land And Improvements |
|
—
|
9.38
-59.16%
|
22.96
+0.48%
|
22.85
|
| Buildings And Improvements |
|
13.52
-43.55%
|
23.95
-88.14%
|
201.94
+2.39%
|
197.23
|
| Machinery Furniture Equipment |
|
—
|
472.59
-4.05%
|
492.55
+4.78%
|
470.07
|
| Construction In Progress |
|
—
|
32.19
+200.01%
|
10.73
-25.50%
|
14.40
|
| Other Properties |
|
559.33
+4.35%
|
536.00
-18.63%
|
658.73
+8.94%
|
604.67
|
| Goodwill And Other Intangible Assets |
|
1,364.61
-5.12%
|
1,438.20
-28.11%
|
2,000.68
-3.89%
|
2,081.75
|
| Goodwill |
|
1,228.14
+0.00%
|
1,228.14
-25.06%
|
1,638.85
+0.13%
|
1,636.70
|
| Other Intangible Assets |
|
136.47
-35.03%
|
210.06
-41.95%
|
361.83
-18.70%
|
445.04
|
| Other Non Current Assets |
|
174.03
-78.80%
|
820.73
+449.55%
|
149.35
-0.71%
|
150.42
|
| Total Liabilities Net Minority Interest |
|
2,912.74
-28.43%
|
4,069.79
-2.38%
|
4,169.16
-6.11%
|
4,440.68
|
| Current Liabilities |
|
947.08
-48.86%
|
1,852.05
-2.11%
|
1,891.88
+20.77%
|
1,566.47
|
| Payables And Accrued Expenses |
|
432.99
-0.14%
|
433.61
-66.34%
|
1,288.28
+3.83%
|
1,240.71
|
| Payables |
|
363.56
+1.01%
|
359.93
-69.29%
|
1,171.88
+2.13%
|
1,147.41
|
| Accounts Payable |
|
363.56
+1.01%
|
359.93
-69.29%
|
1,171.88
+2.13%
|
1,147.41
|
| Current Accrued Expenses |
|
69.43
-5.77%
|
73.68
-36.70%
|
116.40
+24.76%
|
93.30
|
| Current Debt And Capital Lease Obligation |
|
250.00
+483.21%
|
42.87
-79.28%
|
206.90
+1055.50%
|
17.91
|
| Current Debt |
|
250.00
+483.21%
|
42.87
-79.28%
|
206.90
+1055.50%
|
17.91
|
| Other Current Borrowings |
|
—
|
40.00
|
—
|
—
|
| Current Capital Lease Obligation |
|
—
|
5.20
|
—
|
—
|
| Other Current Liabilities |
|
264.08
-80.80%
|
1,375.58
+246.76%
|
396.70
+28.86%
|
307.85
|
| Total Non Current Liabilities Net Minority Interest |
|
1,965.66
-11.37%
|
2,217.74
-2.61%
|
2,277.27
-20.77%
|
2,874.21
|
| Liabilities Heldfor Sale Non Current |
|
0.00
-100.00%
|
237.89
|
—
|
—
|
| Long Term Debt And Capital Lease Obligation |
|
1,870.19
-0.94%
|
1,887.86
-10.66%
|
2,113.03
-21.69%
|
2,698.44
|
| Long Term Debt |
|
1,799.88
+0.08%
|
1,798.39
-4.88%
|
1,890.60
-23.86%
|
2,482.97
|
| Long Term Capital Lease Obligation |
|
70.32
-21.40%
|
89.47
-59.78%
|
222.43
+3.23%
|
215.47
|
| Non Current Deferred Liabilities |
|
0.00
-100.00%
|
19.44
-53.34%
|
41.65
-31.53%
|
60.83
|
| Non Current Deferred Taxes Liabilities |
|
0.00
-100.00%
|
19.44
-53.34%
|
41.65
-31.53%
|
60.83
|
| Other Non Current Liabilities |
|
95.47
+31.59%
|
72.55
-40.82%
|
122.59
+6.65%
|
114.94
|
| Stockholders Equity |
|
-460.98
-178.62%
|
586.36
-36.55%
|
924.17
-2.27%
|
945.60
|
| Common Stock Equity |
|
-460.98
-178.62%
|
586.36
-36.55%
|
924.17
-2.27%
|
945.60
|
| Capital Stock |
|
152.78
-1.05%
|
154.40
+0.85%
|
153.09
+0.35%
|
152.56
|
| Common Stock |
|
152.78
-1.05%
|
154.40
+0.85%
|
153.09
+0.35%
|
152.56
|
| Share Issued |
|
76.39
-1.05%
|
77.20
+0.85%
|
76.55
+0.35%
|
76.28
|
| Ordinary Shares Number |
|
76.39
-1.05%
|
77.20
+0.85%
|
76.55
+0.35%
|
76.28
|
| Additional Paid In Capital |
|
466.88
+2.80%
|
454.15
+4.60%
|
434.19
+3.65%
|
418.89
|
| Retained Earnings |
|
-1,079.75
-4075.67%
|
27.16
-92.63%
|
368.71
-10.07%
|
410.01
|
| Gains Losses Not Affecting Retained Earnings |
|
-0.89
+98.21%
|
-49.34
-55.08%
|
-31.82
+11.26%
|
-35.85
|
| Other Equity Adjustments |
|
-0.89
+98.21%
|
-49.34
-55.08%
|
-31.82
+11.26%
|
-35.85
|
| Total Equity Gross Minority Interest |
|
-460.98
-178.62%
|
586.36
-36.55%
|
924.17
-2.27%
|
945.60
|
| Total Capitalization |
|
1,338.90
-43.86%
|
2,384.76
-15.28%
|
2,814.76
-17.90%
|
3,428.57
|
| Working Capital |
|
-399.20
-336.26%
|
168.97
-19.89%
|
210.91
-71.06%
|
728.72
|
| Invested Capital |
|
1,588.90
-34.55%
|
2,427.62
-19.66%
|
3,021.67
-12.33%
|
3,446.48
|
| Total Debt |
|
2,120.19
+9.81%
|
1,930.72
-16.78%
|
2,319.93
-14.59%
|
2,716.34
|
| Net Debt |
|
1,767.89
-2.53%
|
1,813.69
-2.20%
|
1,854.46
-23.73%
|
2,431.41
|
| Capital Lease Obligations |
|
70.32
-21.40%
|
89.47
-59.78%
|
222.43
+3.23%
|
215.47
|
| Net Tangible Assets |
|
-1,825.58
-114.31%
|
-851.83
+20.87%
|
-1,076.52
+5.25%
|
-1,136.14
|
| Tangible Book Value |
|
-1,825.58
-114.31%
|
-851.83
+20.87%
|
-1,076.52
+5.25%
|
-1,136.14
|
| Inventories Adjustments Allowances |
|
—
|
-64.96
+16.92%
|
-78.19
|
—
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-101.79
-163.03%
|
161.50
-78.20%
|
740.71
+127.91%
|
325.01
|
| Cash Flow From Continuing Operating Activities |
|
154.50
+7.52%
|
143.69
-57.29%
|
336.46
+3.52%
|
325.01
|
| Cash From Discontinued Operating Activities |
|
-256.29
-1539.08%
|
17.81
-95.59%
|
404.25
|
—
|
| Net Income From Continuing Operations |
|
-102.68
+70.72%
|
-350.74
-4038.63%
|
8.90
-60.23%
|
22.39
|
| Depreciation Amortization Depletion |
|
214.52
+18.34%
|
181.28
-13.83%
|
210.37
-8.00%
|
228.67
|
| Depreciation And Amortization |
|
214.52
+18.34%
|
181.28
-13.83%
|
210.37
-8.00%
|
228.67
|
| Other Non Cash Items |
|
9.73
+7.13%
|
9.09
-6.88%
|
9.76
-21.91%
|
12.49
|
| Stock Based Compensation |
|
12.87
-22.63%
|
16.64
+15.58%
|
14.39
-31.43%
|
20.99
|
| Provisionand Write Offof Assets |
|
—
|
—
|
-1.41
-142.65%
|
3.31
|
| Asset Impairment Charge |
|
0.00
-100.00%
|
307.11
|
0.00
|
0.00
|
| Deferred Tax |
|
-17.89
-122.42%
|
-8.04
-33.94%
|
-6.00
+77.22%
|
-26.36
|
| Deferred Income Tax |
|
-17.89
-122.42%
|
-8.04
-33.94%
|
-6.00
+77.22%
|
-26.36
|
| Operating Gains Losses |
|
-27.27
+20.38%
|
-34.25
+10.80%
|
-38.40
-46.23%
|
-26.26
|
| Gain Loss On Sale Of PPE |
|
-27.27
+22.86%
|
-35.35
-1.36%
|
-34.88
-32.83%
|
-26.26
|
| Change In Working Capital |
|
65.21
+188.53%
|
22.60
-83.56%
|
137.43
+47.65%
|
93.08
|
| Change In Receivables |
|
122.36
+3427.79%
|
-3.68
+59.10%
|
-8.99
-303.60%
|
4.42
|
| Changes In Account Receivables |
|
122.36
+3427.79%
|
-3.68
+59.10%
|
-8.99
-303.60%
|
4.42
|
| Change In Inventory |
|
-6.85
-49.29%
|
-4.59
+14.22%
|
-5.35
-103.21%
|
166.56
|
| Change In Payables And Accrued Expense |
|
6.48
-90.32%
|
66.89
+1175.39%
|
5.25
-61.58%
|
13.65
|
| Change In Payable |
|
6.48
-90.32%
|
66.89
+1175.39%
|
5.25
-61.58%
|
13.65
|
| Change In Account Payable |
|
6.48
-90.32%
|
66.89
+1175.39%
|
5.25
-61.58%
|
13.65
|
| Change In Other Working Capital |
|
-56.78
-57.61%
|
-36.03
-124.59%
|
146.53
+260.07%
|
-91.54
|
| Investing Cash Flow |
|
144.42
+223.93%
|
-116.53
+15.10%
|
-137.25
+92.39%
|
-1,804.48
|
| Cash Flow From Continuing Investing Activities |
|
198.99
+302.98%
|
-98.04
+9.14%
|
-107.89
+94.02%
|
-1,804.48
|
| Cash From Discontinued Investing Activities |
|
-54.57
-195.02%
|
-18.50
+37.00%
|
-29.36
|
—
|
| Net PPE Purchase And Sale |
|
-112.99
-12.58%
|
-100.36
+0.44%
|
-100.80
+8.12%
|
-109.71
|
| Purchase Of PPE |
|
-190.96
-12.14%
|
-170.29
+1.21%
|
-172.38
-9.04%
|
-158.09
|
| Sale Of PPE |
|
77.97
+11.50%
|
69.93
-2.30%
|
71.57
+47.93%
|
48.38
|
| Capital Expenditure |
|
-201.32
-10.22%
|
-182.66
-2.32%
|
-178.53
-7.17%
|
-166.58
|
| Net Business Purchase And Sale |
|
324.26
|
0.00
|
0.00
+100.00%
|
-1,684.61
|
| Purchase Of Business |
|
-18.09
|
0.00
|
0.00
+100.00%
|
-1,684.61
|
| Gain Loss On Sale Of Business |
|
—
|
—
|
—
|
0.00
|
| Net Intangibles Purchase And Sale |
|
-10.37
+16.24%
|
-12.38
-101.09%
|
-6.16
+27.51%
|
-8.49
|
| Purchase Of Intangibles |
|
-10.37
+16.24%
|
-12.38
-101.09%
|
-6.16
+27.51%
|
-8.49
|
| Net Other Investing Changes |
|
-1.91
-112.99%
|
14.70
+1670.83%
|
-0.94
+43.95%
|
-1.67
|
| Financing Cash Flow |
|
188.08
+170.28%
|
-267.60
+35.88%
|
-417.33
-127.88%
|
1,497.11
|
| Cash Flow From Continuing Financing Activities |
|
190.21
+176.08%
|
-250.02
+39.18%
|
-411.06
-127.46%
|
1,497.11
|
| Net Issuance Payments Of Debt |
|
203.50
+183.33%
|
-244.20
+41.40%
|
-416.69
-126.33%
|
1,582.50
|
| Issuance Of Debt |
|
2,914.78
+38.69%
|
2,101.60
+341.51%
|
476.00
-82.65%
|
2,743.30
|
| Repayment Of Debt |
|
-2,711.28
-15.58%
|
-2,345.80
-162.78%
|
-892.69
+23.10%
|
-1,160.80
|
| Long Term Debt Issuance |
|
2,914.78
+38.69%
|
2,101.60
+341.51%
|
476.00
-82.65%
|
2,743.30
|
| Long Term Debt Payments |
|
-2,711.28
-15.58%
|
-2,345.80
-162.78%
|
-892.69
+23.10%
|
-1,160.80
|
| Net Long Term Debt Issuance |
|
203.50
+183.33%
|
-244.20
+41.40%
|
-416.69
-126.33%
|
1,582.50
|
| Short Term Debt Payments |
|
—
|
—
|
—
|
—
|
| Net Short Term Debt Issuance |
|
—
|
—
|
0.00
-100.00%
|
30.00
|
| Net Common Stock Issuance |
|
-10.18
|
0.00
|
0.00
|
0.00
|
| Common Stock Payments |
|
-10.18
|
0.00
|
0.00
|
—
|
| Common Stock Dividend Paid |
|
—
|
—
|
0.00
|
0.00
|
| Cash Dividends Paid |
|
—
|
—
|
0.00
|
0.00
|
| Repurchase Of Capital Stock |
|
-10.18
|
0.00
|
0.00
|
—
|
| Proceeds From Stock Option Exercised |
|
—
|
—
|
0.00
|
0.00
|
| Net Other Financing Charges |
|
-3.12
+46.52%
|
-5.83
-203.35%
|
5.64
+106.60%
|
-85.39
|
| Changes In Cash |
|
230.71
+203.62%
|
-222.64
-219.62%
|
186.13
+955.44%
|
17.64
|
| Effect Of Exchange Rate Changes |
|
1.90
+310.43%
|
-0.90
-246.98%
|
0.61
+117.59%
|
-3.48
|
| Beginning Cash Position |
|
49.38
-81.91%
|
272.92
+216.67%
|
86.19
+19.64%
|
72.03
|
| End Cash Position |
|
281.99
+471.04%
|
49.38
-81.91%
|
272.92
+216.67%
|
86.19
|
| Free Cash Flow |
|
-303.12
-1331.81%
|
-21.17
-103.77%
|
562.18
+254.86%
|
158.42
|
| Interest Paid Supplemental Data |
|
134.71
-4.83%
|
141.55
-7.63%
|
153.25
+43.19%
|
107.02
|
| Income Tax Paid Supplemental Data |
|
12.47
+124.58%
|
5.55
-11.62%
|
6.28
-81.51%
|
33.97
|
| Common Stock Issuance |
|
—
|
—
|
—
|
0.00
|
| Interest Paid CFF |
|
—
|
—
|
—
|
-42.60
|
| Issuance Of Capital Stock |
|
—
|
—
|
—
|
0.00
|
| Sale Of Business |
|
342.35
|
0.00
|
0.00
|
0.00
|
| Cash From Discontinued Financing Activities |
|
-2.13
+87.90%
|
-17.58
-180.20%
|
-6.27
|
—
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42026-03-24 View
- 42026-03-24 View
- 42026-03-24 View
- 42026-03-24 View
- 42026-03-10 View
- 42026-03-10 View
- 42026-03-10 View
- 10-K2026-02-20 View
- 8-K2026-02-19 View
- 8-K2025-12-31 View
- 8-K2025-12-18 View
- 8-K2025-12-08 View
- 8-K2025-12-02 View
- 42025-11-20 View
- 10-Q2025-10-31 View
- 8-K2025-10-30 View
- 8-K2025-10-07 View
- 42025-09-24 View
- 8-K2025-09-19 View
- 42025-08-14 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|